Erratum to: A multicenter study of septic shock due to candidemia: Outcomes and predictors of mortality (Intensive Care Medicine (2014) 40, (839-845) DOI: 10.1007/s00134-014-3310-z);A multicenter study of septic shock due to candidemia: Outcomes and predictors of mortality

Intensive Care Medicine

Volumn 40, Issue 6, 2014, Pages 839-845

  Bassetti, Matteo ^a   Righi, Elda ^a   Ansaldi, Filippo ^b   Merelli, Maria ^a   Cecilia, Trucchi ^b   De Pascale, Gennaro ^c   Diaz Martin, Ana ^d   Luzzati, Roberto ^e   Rosin, Chiara ^e   Lagunes, Leonel ^f   Trecarichi, Enrico Maria ^c   Sanguinetti, Maurizio ^c   Posteraro, Brunella ^c   Garnacho Montero, Jose ^d   Sartor, Assunta ^g   Rello, Jordi ^f   Rocca, Giorgio Della ^g   Antonelli, Massimo ^c   Tumbarello, Mario ^c  

^a UNIVERSITY HOSPITAL OF UDINE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^e UNIVERSITY HOSPITAL OF TRIESTE   (Italy)

^f HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^g S Maria Hospital   (Italy)

Author keywords

Candidemia; Catheter; Echinocandins; Fluconazole; Septic shock; Source control

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; AMPHOTERICIN LIPID COMPLEX; ANIDULAFUNGIN; ANTIFUNGAL AGENT; CASPOFUNGIN; FLUCONAZOLE; MICAFUNGIN; UNCLASSIFIED DRUG;

ADULT; AGED; APACHE; ARTICLE; BLOOD CULTURE; CANDIDEMIA; COHORT ANALYSIS; CRITICALLY ILL PATIENT; FEMALE; HUMAN; INTENSIVE CARE UNIT; ITALY; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PREDICTION; RETROSPECTIVE STUDY; RISK FACTOR; SEPTIC SHOCK; SPAIN; SURVIVOR; TEACHING HOSPITAL; CLINICAL TRIAL; COMPLICATION; MICROBIOLOGY; MIDDLE AGED; PROGNOSIS; SHOCK, SEPTIC; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; CANDIDEMIA; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SHOCK, SEPTIC; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84901407702     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-014-3387-4     Document Type: Erratum

References (26)

1. Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C (2005) The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis 41(9):1232-1239 (Pubitemid 41532664)
2. Wenzel RP (1995) Nosocomial candidemia: risk factors and attributable mortality. Clin Infect Dis 20(6):1531-1534
3. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39(3):309-317 (Pubitemid 39050477)
4. Marchetti O, Bille J, Fluckiger U, Eggimann P, Ruef C, Garbino J, Calandra T, Glauser MP, Tauber MG, Pittet D et al (2004) Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. Clin Infect Dis 38(3):311-320 (Pubitemid 38200105)
5. Bassetti M, Taramasso L, Nicco E, Molinari MP, Mussap M, Viscoli C (2011) Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. PLoS One 6(9):e24198
6. Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, Olyaei AJ, Marr KA, Pfaller MA, Chang CH, Webster KM (2009) Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 48(12):1695-1703
7. Ostrosky-Zeichner L, Pappas PG (2006) Invasive candidiasis in the intensive care unit. Crit Care Med 34(3):857-863
8. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y et al (2009) International study of the prevalence and outcomes of infection in intensive care units. JAMA 302(21):2323-2329
9. Eggimann P, Garbino J, Pittet D (2003) Epidemiology of Candida species infections in critically ill nonimmunosuppressed patients. Lancet Infect Dis 3(11):685-702 (Pubitemid 37345347)
10. Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB (2006) Inflammatory response and clinical course of adult patients with nosocomial bloodstream infections caused by Candida spp. Clin Microbiol Infect 12(2):170-177 (Pubitemid 43379346)
11. Guery BP, Arendrup MC, Auzinger G, Azoulay E, Borges Sa M, Johnson EM, Muller E, Putensen C, Rotstein C, Sganga G (2009) Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis. Intensive Care Med 35(1):55-62
12. Gutierrez SM, Heredia M, Gomez E, Gomez JI, Tamayo E (2013) Candidemia in ICU patients with sepsis. Crit Care Med 41(11):e385
13. Delaloye J, Calandra T (2014) Invasive candidiasis as a cause of sepsis in the critically ill patient. Virulence 5(1):161-169
14. Guzman JA, Tchokonte R, Sobel JD (2011) Septic shock due to candidemia: outcomes and predictors of shock development. J Clin Med Res 3(2):65-71
15. Leroy O, Gangneux JP, Montravers P, Mira JP, Gouin F, Sollet JP, Carlet J, Reynes J, Rosenheim M, Regnier B et al (2009) Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Crit Care Med 37(5):1612-1618
16. Kollef M, Micek S, Hampton N, Doherty JA, Kumar A (2012) Septic shock attributed to Candida infection: importance of empiric therapy and source control. Clin Infect Dis 54(12):1739-1746
17. Bassetti M, Molinari MP, Mussap M, Viscoli C, Righi E (2013) Candidaemia in internal medicine departments: the burden of a rising problem. Clin Microb Infect 19(6):E281-E284
18. Garey KW, Rege M, Pai MP, Mingo DE, Suda KJ, Turpin RS, Bearden DT (2006) Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis 43(1):25-31 (Pubitemid 43939072)
19. Morrell M, Fraser VJ, Kollef MH (2005) Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agenst Chemother 49(9):3640-3645 (Pubitemid 41233011)
20. Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, Lortholary O, Meersseman W, Akova M, Arendrup MC, Arikan-Akdagli S et al (2012) ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microb Infect 18[Suppl 7]:19-37
21. Reboli AC, Shorr AF, Rotstein C, Pappas PG, Kett DH, Schlamm HT, Reisman AL, Biswas P, Walsh TJ (2011) Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome. BMC Infect Dis 11:261
22. Bassetti M, Merelli M, Righi E, Diaz- Martin A, Rosello EM, Luzzati R, Parra A, Trecarichi EM, Sanguinetti M, Posteraro B et al (2013) Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain. J Clin Microbiol 51(12):4167-4172
23. Kett DH, Azoulay E, Echeverria PM, Vincent JL (2011) Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in an intensive care unit study. Crit Care Med 39(4):665-670
24. Ferrada MA, Quartin AA, Kett DH, Morris MI (2013) Candidemia in the critically ill: initial therapy and outcome in mechanically ventilated patients. BMC Anesthesiol 13(1):37
25. Andes DR, Safdar N, Baddley JW, Playford G, Reboli AC, Rex JH, Sobel JD, Pappas PG, Kullberg BJ (2012) Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis 54(8):1110-1122
26. Nucci M, Anaissie E, Betts RF et al (2010) Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials. Clin Infect Dis 51:295-303